Despite the anti-PD-1/PD-L1 antibodies, soluble PD-1 (sPD-1) peptides may provide similar inhibition effect of PD-1 pathway by competitively binding to PD-L1 expressed on tumor cells. The gene discussed is PDCD1; the disease is neoplasm.